GoDx, Inc.
GoDx is dedicated to improving global health by providing accessible diagnostics for all people. Their mission is to empower individuals with the knowledge of their health status anytime and anywhere, focusing on point-of-care (POC) solutions for detecting gastrointestinal pathogens and their associated antimicrobial resistance (AMR) genes.
Industries
Nr. of Employees
small (1-50)
GoDx, Inc.
Madison, Wisconsin, United States, North America
Products
Paper-strip stool pathogen DNA test (Research Use Only)
A research-use-only, instrument-free paper-strip test that amplifies gut pathogen DNA via isothermal amplification and detects amplicons on lateral-flow paper strips. Targets include common enteric bacteria such as Salmonella, Shigella, Campylobacter and STEC.
Rapid lateral-flow nucleic acid detection strips
Lateral-flow strips designed to detect labeled nucleic acid amplicons (fluorescein/biotin) with high sensitivity and rapid visual readout; compatible with multiple amplification chemistries and suitable for multiplexing.
Paper-strip stool pathogen DNA test (Research Use Only)
A research-use-only, instrument-free paper-strip test that amplifies gut pathogen DNA via isothermal amplification and detects amplicons on lateral-flow paper strips. Targets include common enteric bacteria such as Salmonella, Shigella, Campylobacter and STEC.
Rapid lateral-flow nucleic acid detection strips
Lateral-flow strips designed to detect labeled nucleic acid amplicons (fluorescein/biotin) with high sensitivity and rapid visual readout; compatible with multiple amplification chemistries and suitable for multiplexing.
Services
Collaborative R&D and clinical validation partnerships
Partnered development and clinical validation projects for paper-based point-of-care molecular assays, including academic and government collaborations and grant-supported programs.
Prototype development of paper-based instrument-free nucleic acid tests
Design and prototyping of lateral-flow based nucleic acid assays optimized for low-cost, instrument-free operation and short time-to-result.
Collaborative R&D and clinical validation partnerships
Partnered development and clinical validation projects for paper-based point-of-care molecular assays, including academic and government collaborations and grant-supported programs.
Prototype development of paper-based instrument-free nucleic acid tests
Design and prototyping of lateral-flow based nucleic acid assays optimized for low-cost, instrument-free operation and short time-to-result.
Expertise Areas
- Point-of-care molecular diagnostics
- Lateral flow assay development
- Isothermal nucleic acid amplification
- Multiplex molecular detection
Key Technologies
- Lateral flow assays (paper-based)
- Isothermal amplification (e.g., RPA, LAMP)
- Polymerase chain reaction (PCR)
- CRISPR-based nucleic acid detection